The Journal of Neurology has reported that common forms of Hormone Replacement Therapy (HRT) can shrink the brains of post-menopausal women. Researchers performed brain scans on 1,400 women aged 71 to 89 who participated in the Women’s Health Initiative, A major American Study.
The Study found that women who were being administered HRT had smaller brain volumes in two key areas than those given a placebo. Brain volume was lower in the frontal lobe and in the hippocampus. Both of these areas of the brain contribute to thinking and memory skills. Shrinkage of the hippocampus is a known risk factor for dementia.
This Study was ironically renowned for finding a link between long term HRT use and increased stroke risk. The question that must be examined is whether the Pharmaceutical Industry is going to continue to be allowed to obtain approval of their products without greater scrutiny.
The conventional wisdom is that the American F.D.A., which regulates the Pharmaceutical Industry, has the most stringent and arduous approval process on the planet. However, conventional wisdom appears to be nothing more than American Corporate propaganda as the overwhelming number of drugs that have been recalled or that have caused significant health problems has been staggering over the past ten years.
Too, often, we learn of the politicizing of the F.D.A., which is given its marching orders to treat the pharmaceutical industry with kid gloves. Former industry personnel end up working for the agency that is supposed to regulate the very same industry they just left, and are going to return to after this government stint.
We are supposed to have a government for the people, not for the corporations. Hopefully, the pendulum will be shifting back.